Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Cancer Research

• Publication date

  1989-04-15

• Fields of study

  Medicine

• Identifiers
  PMID 2522814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presence of a growth-stimulating factor in serum following primary tumor removal in mice.

  1989cited by this paper
• Influence of irradiation of a primary tumor on the labeling index and estrogen receptor index in a distant tumor focus.

  1986cited by this paper
• Interrelation between tumor cell proliferation and 17-fluoresceinated estrone binding following primary tumor removal, radiation, cyclophosphamide, or tamoxifen.

  1983influential reference
• Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.

  1983cited by this paper
• Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer

  1983cited by this paper
• Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx

  1983cited by this paper
• Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

  1982cited by this paper
• A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

  1979cited by this paper
• Effect of surgical removal on the growth and kinetics of residual tumor.

  1979influential reference
• A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

  1979cited by this paper

• PD-1/PD-L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)

  2023cites this paper
• Does Primary Tumor Resection Induce Accelerated Metastasis in Breast Cancer? A Review.

  2023cites this paper
• Short-Term Outcomes Following Breast Cancer Surgery With and Without Neoadjuvant Chemotherapy: A Nationwide Administrative Database Study in Japan

  2022cites this paper
• Systemic therapy for early-stage breast cancer: learning from the past to build the future

  2022cites this paper
• The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer

  2021cites this paper
• CMAR_A_262870 2567..2579

  2021cites this paper
• Current management of melanoma patients with nodal metastases

  2021cites this paper
• Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

  2020cites this paper
• Neoadjuvant chemotherapy: practice and thinking for Chinese patients with early breast cancer

  2020cites this paper
• Adjuvant and neoadjuvant cancer therapies: A historical review and a rational approach to understand outcomes.

  2019cites this paper
• Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

  2019cites this paper
• Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1–NDRG1 axis in both PR-positive and -negative breast cancer cells

  2018cites this paper
• Adjuvant and neoadjuvant systemic therapies for early-stage breast cancer

  2018cites this paper
• Effects of neoadjuvant chemotherapy on the depth of total intravenous anesthesia in patients with breast cancer undergoing unilateral modified radical mastectomy

  2018cites this paper
• Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity

  2018cites this paper
• Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy

  2018cites this paper
• Surgical Risk Factors for the Delayed Initiation of Adjuvant Chemotherapy in Breast Cancer

  2018cites this paper
• Carcinoma of the Esophagus April

  2017cites this paper
• Timing of Breast Cancer Surgery—How Much Does It Matter?

  2017cites this paper
• Mathematical modeling of tumor-tumor distant interactions supports a systemic control of tumor growth

  2017cites this paper
• Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients.

  2017cites this paper
• Locally Ablative Radiation Therapy of a Primary Human Small Cell Lung Cancer Tumor Decreases the Number of Spontaneous Metastases in Two Xenograft Models.

  2017cites this paper
• Implicaciones clínicas y factores predictivo-pronósticos de la quimioterapia primaria en el cáncer de mama localmente avanzado

  2016cites this paper
• A prognostic index for locoregional recurrence after neoadjuvant chemotherapy

  2016cites this paper
• Timing of breast cancer surgery, menstrual phase, and prognosis: Systematic review and meta-analysis.

  2016cites this paper
• Early Surrogate Markers of Treatment Activity: Where Are We Now?

  2015cites this paper
• A Hypothesis Concerning the Biphasic Dose-response of Tumors to Angiostatin and Endostatin

  2015cites this paper
• Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer.

  2015cites this paper
• Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.

  2015cites this paper
• Early initiation of fluorouracil-based adjuvant chemotherapy improves survival in patients with resectable gastric cancer.

  2015cites this paper
• A case of gastric cancer with para-aortic lymphnode metastasis responding to preoperative chemotherapy completely on pathology and surviving 5 years without recurrence

  2013cites this paper
• Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.

  2013cites this paper
• Modern Risk Assessment for Individualizing Treatment Concepts in Early-stage Breast Cancer.

  2013cites this paper
• Regulation of tumor dormancy and role of microenvironment: a mathematical model.

  2013cites this paper
• Neoadjuvant Chemotherapy for Breast Cancer

  2013cites this paper
• Early breast cancer: From screening to multidisciplinary management, third edition

  2013cites this paper
• Un cas de ré-irradiation cutanée mammaire

  2012cites this paper
• Neoadjuvant Therapy in Breast Cancer

  2012cites this paper
• Patient and tumor characteristics associated with breast cancer recurrence after complete pathological response to neoadjuvant chemotherapy

  2012cites this paper
• [A case of cutaneous mammary re-irradiation].

  2012cites this paper
• [The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission].

  2012cites this paper
• Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer.

  2011cites this paper
• Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients.

  2011cites this paper
• Patterns in the occurrence and development of tumors.

  2011cites this paper
• Optimal timing of adjuvant treatment in patients with early breast cancer

  2011cites this paper
• Neoadjuvant systemic treatment of breast cancer

  2011cites this paper
• Presurgical progesterone in early breast cancer: so much for so little?

  2011cites this paper
• [Neoadjuvant therapy in breast cancer].

  2011cites this paper
• Result of Neoadjuvant Chemotherapy, Surgery and Radiation Therapy in Locally Advanced Breast Cancer

  2010cites this paper
• An enzyme kinetics model of tumor dormancy, regulationof secondary metastases

  2010cites this paper
• Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancer.

  2010cites this paper
• Prospective randomized trial of short-term neoadjuvant chemotherapy for advanced gastric cancer.

  2010cites this paper
• Neoadjuvant therapy for breast cancer

  2010cites this paper
• Guidelines on the radical management of patients with lung cancer

  2010cites this paper
• What's new in neoadjuvant therapy for breast cancer?

  2010cites this paper
• Breast cancer therapy: the role of PET-CT in decision making.

  2009cites this paper
• Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902

  2009cites this paper
• Does neoadjuvant chemotherapy increase breast conservation in operable breast cancer: an Egyptian experience

  2009cites this paper
• Neoadjuvant chemotherapy in patients with stages II and III breast cancer.

  2009cites this paper
• Breast cancer: role of neoadjuvant therapy.

  2009cites this paper
• Perioperative therapy in HER2+ patients

  2009cites this paper
• 術前補助化学療法としてS-1/paclitaxel併用療法を施行しpathological CRが得られた進行胃癌の2例

  2009cites this paper
• CyberKnife® et chimiothérapie néoadjuvante pour les tumeurs du sein localement évoluées : résultats préliminaires

  2009cites this paper
• Systemic effects of local radiotherapy.

  2009cites this paper
• [CyberKnife and neoadjuvant chemotherapy for breast tumors: preliminary results].

  2009cites this paper
• Focus On Perioperative therapy in HER2 1 patients

  2009cites this paper
• Predictive markers of response to neoadjuvant chemotherapy in breast cancer.

  2008cites this paper
• The potential risk of neoadjuvant chemotherapy in breast cancer patients—results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)

  2008cites this paper
• Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.

  2007cites this paper
• Evaluation of the vascular response to neoadjuvant chemotherapy in primary breast cancer.

  2007cites this paper
• Endocrine therapy for breast cancer: an overview.

  2007cites this paper
• Neoadjuvant chemotherapy in women with large and locally advanced breast cancer: chemoresistance and prediction of response to drug therapy.

  2006cites this paper
• Preoperative Chemotherapy in Primary O perable Breast Cancer: Resu lts From the Eu ropean O rganization for Research and Treatment of Cancer Trial 10902

  2006cites this paper
• Preoperative Chemotherapy in Primary O perable B reast Cancer: R esu lts From the Eu ropean O rganization for R esearch and Treatment of Cancer Trial 10902

  2006cites this paper
• Breast conservation after neoadjuvant chemotherapy

  2005cites this paper
• Neoadjuvant chemotherapy in breast cancer

  2005cites this paper
• Primary chemotherapy : A better overall therapeutic option for patients with breast cancer

  2005influential citation
• Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival.

  2005cites this paper
• State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments

  2005cites this paper
• Anaesthetic implications of anticancer chemotherapy.

  2005cites this paper
• Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)

  2005cites this paper
• Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative Therapy

  2005cites this paper
• Controversies in breast cancer: adjuvant and neoadjuvant therapy

  2005cites this paper
• Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.

  2005cites this paper
• State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments Aktueller Stand der neoadjuvanten Chemotherapie des Mammakarzinoms: Gründe, Resultate und neuere Entwicklungen

  2005cites this paper
• The outcome of treatment of breast cancer in a developing country--Oman.

  2004cites this paper
• Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.

  2004cites this paper
• [Does primary chemotherapy really increase the rate of breast conserving treatments?].

  2004cites this paper
• Chimiothérapie néo–adjuvante: justificatif historique et expérimental

  2004cites this paper
• Cancer du sein. Traitements néo–adjuvants. Radiothérapie náo–adjuvante ou radio–chimiothárapie néo-adjuvante

  2004cites this paper
• Facteurs prédictifs de réponse àla chimiothérapie néo-adjuvante : un modèle mal utilisé

  2004cites this paper
• Preoperative chemotherapy and endocrine therapy in patients with breast cancer.

  2004cites this paper
• Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.

  2004cites this paper
• La chimiothérapie première permet-elle réellement d’augmenter le taux de conservation mammaire ?

  2004cites this paper
• Single-Agent Epirubicin as Primary Chemotherapy in T2–T3, N0–N2, M0 Breast Carcinoma: 6-Year Follow-Up

  2004cites this paper
• Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer.

  2003cites this paper
• Maintaining treatment of locally advanced breast cancer

  2003cites this paper
• Does timing of adjuvant chemotherapy for early breast cancer influence survival?

  2003cites this paper
• Is there still a role for neoadjuvant therapy in breast cancer?

  2003cites this paper
• Preoperative models to evaluate endocrine strategies for breast cancer.

  2003cites this paper